| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.9M | -32.9% |
| R&D Expense | $105.9M | +36.4% |
| SG&A Expense | $30.0M | +70.6% |
| Operating Income | -$111.1M | -90.9% |
| Pre-tax Income | -$108.1M | -86.6% |
| Income Tax | $54K | -81.5% |
| Net Income | -$108.2M | -85.8% |
| EPS (Basic) | -$1.23 | -30.9% |
| EPS (Diluted) | -$1.23 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.0M | -58.0% |
| Short-term Investments | $306.2M | -10.6% |
| Accounts Receivable | $2.0M | +0.0% |
| Current Assets | $375.3M | -23.8% |
| Total Assets | $436.5M | -12.7% |
| Current Liabilities | $55.5M | +36.5% |
| Total Liabilities | $187.0M | +20.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$109.1M | -83.2% |
| Capital Expenditures | $7.7M | +318.7% |
| Investing Cash Flow | $26.4M | +114.4% |
| Financing Cash Flow | $1.6M | -99.5% |
| Free Cash Flow | -$116.8M | -90.3% |
| -30.9% |
| Stockholders' Equity |
| $249.5M |
| -27.6% |